Results 11 to 20 of about 276,829 (341)
Systemic Impact of Helicobacter pylori: A Cross‐Sectional Study [PDF]
JGH OpenBackground and Aim Helicobacter pylori is an oncobacteria that infects about half of the world's population and has a well‐established role in the etiology of gastric diseases.
Amanda Ferreira Paes Landim Ramos +7 more
doaj +2 more sources
The evolution of SARS-CoV-2 and the COVID-19 pandemic [PDF]
PeerJ, 2023 Scientists have made great efforts to understand the evolution of SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) to provide crucial information to public health experts on strategies to control this viral pathogen.
Yuanfang Si +10 more
doaj +2 more sources
Infectious Disease Clinics of North America, 1998 Helicobacter pylori infection causes peptic ulcer disease, gastric adenocarcinoma, gastric lymphoma, and probably nonulcer dyspepsia. Although the prevalence of infection is declining over time, the organism still infects approximately one half of the world's population. Only a minority will ever suffer serious consequences from their infection.
G, Fisher +3 more
+11 more sources
Molecular docking of a set of flavonoid compounds with Helicobacter pylori virulence factors CagA and VacA [PDF]
Journal of HerbMed Pharmacology, 2020 Introduction: Cytotoxin associated gene A (CagA) and vacuolating cytotoxin A (VacA) proteins are the main Helicobacter pylori virulence factors. These toxins are associated with severe gastric diseases.
Mohamed Reda Jouimyi +7 more
doaj +1 more source
Journal of Infection in Developing Countries, 2021 Introduction: Helicobacter pylori infection is the major risk factor of atrophic gastritis and intestinal metaplasia. The vacA gene is one of the most virulence factors of H.
Mohamed Reda Jouimyi +9 more
doaj +1 more source
AORN Journal, 1997 Helicobacter pylori is a gram-negative bacterium which causes chronic gastritis and plays important roles in peptic ulcer disease, gastric carcinoma, and gastric lymphoma. H. pylori has been found in the stomachs of humans in all parts of the world. In developing countries, 70 to 90% of the population carries H. pylori.
B E, Dunn, H, Cohen, M J, Blaser
openaire +4 more sources
Medical Clinics of North America, 2000 H. pylori infection is now recognized as causing serious and life threatening disease in 20% to 30% of those infected. Reliable therapy is problematic. This article addresses the current approach to diagnosis and therapy and new considerations regarding whom to treat. The emphasis of the association of the gastric cancer phenotype of H.
A, Shiotani +3 more
openaire +4 more sources
Relationship Between CNVs and Immune Cells Infiltration in Gastric Tumor Microenvironment
Frontiers in Genetics, 2022 Gastric cancer (GC) is a highly fatal and common malignancy of the digestive system. Recent therapeutic advancements have significantly improved the clinical outcomes in GC, but due to the unavailability of suitable molecular targets, a large number of ...
Fazhan Li +17 more
doaj +1 more source
Armeniaspirol A: a novel anti‐Helicobacter pylori agent
Microbial Biotechnology, 2022 Summary Antibiotic resistance in Helicobacter pylori has been growing worldwide with current treatment regimens. Development of new compounds for treatment of H.
Jia Jia +8 more
doaj +1 more source
The impact of dioctyl phthalate exposure on multiple organ systems and gut microbiota in mice
Heliyon, 2023 Dioctyl phthalate, commonly known as bis(2-ethylhexyl) phthalate (DEHP), is a widely used plasticizer in various industries and has been shown to directly or indirectly impact human health. However, there is a lack of comprehensive studies evaluating the
Qiang Zhang +7 more
doaj +1 more source